Our results are in line with Kaporis et al (2007) demonstrating abundant CD8+ T cells and increased expression of IFN-associated genes in the BCC immune microenvironment, suggesting a host antitumor response [7]. The gene discussed is CD8A; the disease is skin basal cell carcinoma.